DK0810205T3 - Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem - Google Patents
Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende demInfo
- Publication number
- DK0810205T3 DK0810205T3 DK97108012T DK97108012T DK0810205T3 DK 0810205 T3 DK0810205 T3 DK 0810205T3 DK 97108012 T DK97108012 T DK 97108012T DK 97108012 T DK97108012 T DK 97108012T DK 0810205 T3 DK0810205 T3 DK 0810205T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- naphthoylguanidines
- substituted
- preparation
- methods
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 2
- 239000003814 drug Substances 0.000 title 2
- 229940039227 diagnostic agent Drugs 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 title 1
- APOPAXUENTVHHC-UHFFFAOYSA-N n-(diaminomethylidene)naphthalene-1-carboxamide Chemical class C1=CC=C2C(C(=O)NC(=N)N)=CC=CC2=C1 APOPAXUENTVHHC-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19621482A DE19621482A1 (de) | 1996-05-29 | 1996-05-29 | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0810205T3 true DK0810205T3 (da) | 2001-07-16 |
Family
ID=7795548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97108012T DK0810205T3 (da) | 1996-05-29 | 1997-05-16 | Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6600072B2 (https=) |
| EP (1) | EP0810205B1 (https=) |
| JP (1) | JP4039587B2 (https=) |
| KR (1) | KR970074753A (https=) |
| CN (1) | CN1062859C (https=) |
| AR (1) | AR007299A1 (https=) |
| AT (1) | ATE200076T1 (https=) |
| AU (1) | AU710258B2 (https=) |
| BR (1) | BR9703342A (https=) |
| CA (1) | CA2206362C (https=) |
| CZ (1) | CZ292441B6 (https=) |
| DE (2) | DE19621482A1 (https=) |
| DK (1) | DK0810205T3 (https=) |
| ES (1) | ES2155223T3 (https=) |
| GR (1) | GR3035811T3 (https=) |
| HR (1) | HRP970294B1 (https=) |
| HU (1) | HUP9700954A3 (https=) |
| ID (1) | ID17348A (https=) |
| IL (1) | IL120925A0 (https=) |
| NO (1) | NO308528B1 (https=) |
| NZ (1) | NZ314914A (https=) |
| PL (1) | PL185755B1 (https=) |
| PT (1) | PT810205E (https=) |
| RU (1) | RU2182901C2 (https=) |
| SI (1) | SI0810205T1 (https=) |
| SK (1) | SK282356B6 (https=) |
| TR (1) | TR199700427A2 (https=) |
| TW (1) | TW372955B (https=) |
| ZA (1) | ZA974664B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10023405A1 (de) * | 2000-05-12 | 2001-11-15 | Merck Patent Gmbh | Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen |
| PE20040167A1 (es) * | 2002-03-28 | 2004-05-26 | Novartis Ag | Amidas del acido sulfamico |
| US7365070B2 (en) | 2002-12-04 | 2008-04-29 | Ore Pharmaceuticals Inc. | Modulators of melanocortin receptor |
| JP5030587B2 (ja) * | 2003-06-26 | 2012-09-19 | バイオトロン・リミテッド | 抗ウイルスアシルグアニジン化合物および方法 |
| CA2730116A1 (en) * | 2008-07-08 | 2010-01-14 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4251545A (en) * | 1979-09-19 | 1981-02-17 | Gaf Corporation | Fungicidal process using 1-(alkoxyaroyl)guanidines |
| DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4415873A1 (de) * | 1994-05-05 | 1995-11-09 | Hoechst Ag | Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| JPH08225513A (ja) * | 1994-12-21 | 1996-09-03 | Kanebo Ltd | ナフトイルグアニジン誘導体 |
| JPH08225135A (ja) | 1995-02-21 | 1996-09-03 | Mitsubishi Heavy Ind Ltd | スクリユ−式土砂搬送機 |
| DE19621483A1 (de) | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-05-29 DE DE19621482A patent/DE19621482A1/de not_active Withdrawn
-
1997
- 1997-02-28 PL PL97318724A patent/PL185755B1/pl not_active IP Right Cessation
- 1997-05-16 EP EP97108012A patent/EP0810205B1/de not_active Expired - Lifetime
- 1997-05-16 DK DK97108012T patent/DK0810205T3/da active
- 1997-05-16 PT PT97108012T patent/PT810205E/pt unknown
- 1997-05-16 ES ES97108012T patent/ES2155223T3/es not_active Expired - Lifetime
- 1997-05-16 SI SI9730125T patent/SI0810205T1/xx unknown
- 1997-05-16 DE DE59703220T patent/DE59703220D1/de not_active Expired - Lifetime
- 1997-05-16 AT AT97108012T patent/ATE200076T1/de not_active IP Right Cessation
- 1997-05-27 HR HR970294A patent/HRP970294B1/xx not_active IP Right Cessation
- 1997-05-27 AU AU23713/97A patent/AU710258B2/en not_active Ceased
- 1997-05-27 HU HU9700954A patent/HUP9700954A3/hu unknown
- 1997-05-27 AR ARP970102252A patent/AR007299A1/es unknown
- 1997-05-27 SK SK669-97A patent/SK282356B6/sk unknown
- 1997-05-27 NZ NZ314914A patent/NZ314914A/en unknown
- 1997-05-27 IL IL12092597A patent/IL120925A0/xx not_active IP Right Cessation
- 1997-05-27 TW TW086107121A patent/TW372955B/zh active
- 1997-05-27 TR TR97/00427A patent/TR199700427A2/xx unknown
- 1997-05-27 CZ CZ19971631A patent/CZ292441B6/cs not_active IP Right Cessation
- 1997-05-27 CN CN97113186A patent/CN1062859C/zh not_active Expired - Fee Related
- 1997-05-28 NO NO972434A patent/NO308528B1/no not_active IP Right Cessation
- 1997-05-28 ID IDP971813A patent/ID17348A/id unknown
- 1997-05-28 KR KR1019970021106A patent/KR970074753A/ko not_active Ceased
- 1997-05-28 ZA ZA9704664A patent/ZA974664B/xx unknown
- 1997-05-28 RU RU97109002/04A patent/RU2182901C2/ru not_active IP Right Cessation
- 1997-05-28 JP JP13822697A patent/JP4039587B2/ja not_active Expired - Fee Related
- 1997-05-28 CA CA002206362A patent/CA2206362C/en not_active Expired - Fee Related
- 1997-05-30 BR BR9703342A patent/BR9703342A/pt not_active IP Right Cessation
-
2001
- 2001-04-30 GR GR20010400659T patent/GR3035811T3/el not_active IP Right Cessation
-
2002
- 2002-08-14 US US10/217,457 patent/US6600072B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0807629T3 (da) | Sulfonamidsubstituerede chromaner, fremgangsmåde til fremstilling deraf, anvendelse deraf som medikamenter eller diagnostiske midler samt medikamenter indeholdende dem | |
| NO964639L (no) | Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| DK1222163T3 (da) | 2'-Substituerede 1,1'-biphenyl-2-carboxamider, fremgangsmåder til fremstilling deraf, deres anvendelse som medikament samt farmaceutiske præparater, som indeholder dem | |
| NO972433D0 (no) | Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| NO962006L (no) | Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem | |
| NO960364L (no) | Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| FI953173A0 (fi) | Orto-aminosubstituoituja bentsolyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine | |
| NO960627L (no) | Substituerte benzolsulfonylurinstoffer, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt legemidler inneholdende dem | |
| NO964053D0 (no) | Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| DK0754680T3 (da) | 4-Fluoralkyl-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf | |
| NO983860D0 (no) | Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler | |
| DK0810205T3 (da) | Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem | |
| DK0811610T3 (da) | Ortho-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem | |
| DK0822182T3 (da) | Substituerede indanylidenacetylguanidiner som Na+/H+-udveks-lingsinhibitorer, fremgangsmåde til deres fremstilling, deres anvendelse om lægemidler eller diagnostiske midler samt lægemidler indeholdende dem | |
| NO954739D0 (no) | Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene | |
| NO970697D0 (no) | Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene | |
| NO964812D0 (no) | Sulfonylamino-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| NO972793D0 (no) | Orto-substituerte benzoylguanidiner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| NO995724L (no) | Nye nitrometylketoner, fremgangsmåter for fremstilling av dem, samt preparater som inneholder dem | |
| NO980564D0 (no) | Sulfonamid-substituerte forbindelser, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnådd medikament er beskrevet | |
| NO972406D0 (no) | Bis-orto-substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| DK225189A (da) | Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
| NO970963D0 (no) | Ortosubstituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| DK0869116T3 (da) | Ortho-substituerede benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf | |
| DK0729954T3 (da) | Substituerede thiophenylsulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf |